tm logo
SLIMAMP
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 30 Sep 2021

Last Applicant/ Owned by

12 Michigan Drive

Natick

MA

01760

Serial Number

86620439 filed on 05th May 2015

Registration Number

4974703 registered on 07th Jun 2016

in the Principal Register

Correspondent Address

Viola T. Kung

Viola T. Kung

P.O. Box 2608

Seattle, WA 98111

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

SLIMAMP

Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression, with the aforem Read More

Classification Information


Class [001]
Chemical Products


Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression in the fields of scientific research, clinical research, and scientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research


First Use Date in General

24th Jun 2015

First Use Date in Commerce

24th Jun 2015

Class [005]
Pharmaceutical Products


Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, labels, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulation, transcription, and expression, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments, with the aforementioned reagents being used for medical diagnostic purposes; Biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer


First Use Date in General

24th Jun 2015

First Use Date in Commerce

24th Jun 2015

Mark Details


Serial Number

No 86620439

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 113970-4003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Sep 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
30th Sep 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
30th Sep 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
17th Jun 2021TEAS SECTION 8 & 15 RECEIVED
07th Jun 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07th Jun 2016REGISTERED-PRINCIPAL REGISTER
05th May 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04th May 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26th Apr 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23rd Apr 2016EXTENSION 1 GRANTED